Newsroom

Neopharm Group Acquires Fresenius Biotech

March 3, 2014

Neopharm Group, owned by the Fuhrer family, acquired Fresenius Biotech, a subsidiary of Fresenius SE & Co. KGaA….

Advil – a Superbrand in Israel

December 25, 2012

2012 marks the third year Advil has won “Superbrand” status in the healthcare arena in Israel. This…

Eisai’s Halaven® Approved In Israel

July 12, 2012

HATFIELD, UK 10 July 2012 – Halaven® (eribulin), a novel treatment for patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease, has recently received…

Sativex® receives regulatory approval in Israel

June 13, 2012

Neopharm Group and GW Pharmaceuticals plc announced that Sativex® (Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) oromucosal spray) has received regulatory approval from the Israeli Ministry of Health for the treatment of spasticity and neuropathic pain due…

Neopharm Group Acquires Fresenius Biotech

Advil – a Superbrand in Israel

Eisai’s Halaven® Approved In Israel

Sativex® receives regulatory approval in Israel

Group Companies